Stepping over the line

Administration of Long Acting Injectable Buprenorphine injections by pharmacists has been a 'quantum shift' in the profession's scope of practice  Long Acting Injectable Buprenorphine (LAIB) has been a revolution in the treatment of opioid addiction for a generation of people struggling with the hazardous use of these potent drugs. In 2019 when the first injection

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous PM spruiks double dispensing savings
Next Pharmacies plunged ‘into the dark ages’ but rise to the occasion